Display Settings:

Format

Send to:

Choose Destination
Rheumatol Int. 2011 Jun;31(6):841-2. doi: 10.1007/s00296-010-1485-3. Epub 2010 Apr 8.

Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: comment on the article by Yoo.

Abstract

Several lines of evidence from basic research indicate that B cells may contribute to the pathogenesis of systemic sclerosis. Clinical studies as well have provided preliminary data pointing to the direction that B-cell depletion with rituximab might be a therapeutic option for patients with this debilitating disease.

PMID:
20376665
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Springer
    Loading ...
    Write to the Help Desk